ReviewJournal of thoracic disease2019

Current views on tumor mutational burden in patients with non-small cell lung cancer treated by immune checkpoint inhibitors.

Léa Berland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.